Literature DB >> 17637498

Signals emanating from the membrane proximal region of the thrombopoietin receptor (mpl) support hematopoietic stem cell self-renewal.

Wei Tong1, Yessenia M Ibarra, Harvey F Lodish.   

Abstract

OBJECTIVE: Studies using thrombopoietin -/- (TPO(-/-)) or TPO receptor, mpl(-/-) mice have established a critical role for TPO/mpl signaling in hematopoietic stem cell (HSC) development. In this study, we further dissected mpl signaling in both megakaryopoiesis and HSC function, using mice bearing a truncated mpl receptor lacking the distal 60 amino acids (Delta60). This deletion removes three major signaling tyrosines on the mpl cytoplasmic domain, but retains the membrane proximal Box1 and Box2 domains required for JAK2 activation.
MATERIALS AND METHODS: Competitive bone marrow transplantations (BMT) and serial BMTs were performed to study HSC function. Western blot analysis was used to study TPO-stimulated signaling pathways. BM cell cultures in the presence of TPO were used to study megakaryocyte development.
RESULTS: In agreement with prior findings, we show that Delta60 BM cells cultured in TPO generated normal numbers of megakaryocytes, but with greatly reduced ploidy. As expected from the deletion of three signaling tyrosine residues, freshly isolated Delta60 megakaryocytes showed marked reduction in all known TPO-stimulated signaling pathways tested, including signal transducers and activators of transcription (Stat) 5, Stat3, Akt, and p42/44 mitogen-activated kinase. We found that Delta60 mice displayed normal short-term (ST-HSC) activities and marginally compromised long-term (LT-HSC) stem cell activities in primary transplantation. In addition, Delta60 mice supported HSC self-renewal for at least two serial BMTs.
CONCLUSION: Our data reveal a pivotal role for an unknown signal emanating from the membrane proximal region of the mpl receptor or from JAK2 itself in maintaining stem cell activity and self-renewal, in addition to its role in megakaryocytopoiesis and thrombopoiesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17637498      PMCID: PMC2062518          DOI: 10.1016/j.exphem.2007.05.010

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  28 in total

1.  Role of the distal half of the c-Mpl intracellular domain in control of platelet production by thrombopoietin in vivo.

Authors:  S M Luoh; E Stefanich; G Solar; H Steinmetz; T Lipari; T I Pestina; C W Jackson; F J de Sauvage
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  The distal region and receptor tyrosines of the Epo receptor are non-essential for in vivo erythropoiesis.

Authors:  H Zang; K Sato; H Nakajima; C McKay; P A Ney; J N Ihle
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

3.  Studies with chimeric Mpl/JAK2 receptors indicate that both JAK2 and the membrane-proximal domain of Mpl are required for cellular proliferation.

Authors:  Jonathan G Drachman; Yoshitaka Miyakawa; Jennifer N Luthi; Debra D Dahlen; Alexa Raney; Amy E Geddis; Kenneth Kaushansky
Journal:  J Biol Chem       Date:  2002-04-29       Impact factor: 5.157

4.  Mpl ligand prevents lethal myelosuppression by inhibiting p53-dependent apoptosis.

Authors:  T I Pestina; J L Cleveland; C Yang; G P Zambetti; C W Jackson
Journal:  Blood       Date:  2001-10-01       Impact factor: 22.113

5.  Thrombopoietin expands hematopoietic stem cells after transplantation.

Authors:  Norma Fox; Greg Priestley; Thalia Papayannopoulou; Kenneth Kaushansky
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

6.  Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.

Authors:  Wei Tong; Harvey F Lodish
Journal:  J Exp Med       Date:  2004-08-30       Impact factor: 14.307

7.  Attenuated signaling by a phosphotyrosine-null Epo receptor form in primary erythroid progenitor cells.

Authors:  Ke Li; Madhu P Menon; Vinit G Karur; Shailaja Hegde; Don M Wojchowski
Journal:  Blood       Date:  2003-07-17       Impact factor: 22.113

8.  Differential role of Stat5 isoforms in effecting hematopoietic recovery induced by Mpl-ligand in lethally myelosuppressed mice.

Authors:  Tamara I Pestina; Carl W Jackson
Journal:  Exp Hematol       Date:  2003-12       Impact factor: 3.084

9.  Lyn tyrosine kinase regulates thrombopoietin-induced proliferation of hematopoietic cell lines and primary megakaryocytic progenitors.

Authors:  Brian J Lannutti; Jonathan G Drachman
Journal:  Blood       Date:  2004-01-15       Impact factor: 22.113

Review 10.  Thrombopoietin: a tool for understanding thrombopoiesis.

Authors:  K Kaushansky
Journal:  J Thromb Haemost       Date:  2003-07       Impact factor: 5.824

View more
  18 in total

1.  Cytokines regulating hematopoietic stem cell function.

Authors:  Cheng C Zhang; Harvey F Lodish
Journal:  Curr Opin Hematol       Date:  2008-07       Impact factor: 3.284

2.  Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes.

Authors:  Michael J Kraakman; Man Ks Lee; Annas Al-Sharea; Dragana Dragoljevic; Tessa J Barrett; Emilie Montenont; Debapriya Basu; Sarah Heywood; Helene L Kammoun; Michelle Flynn; Alexandra Whillas; Nordin Mj Hanssen; Mark A Febbraio; Erik Westein; Edward A Fisher; Jaye Chin-Dusting; Mark E Cooper; Jeffrey S Berger; Ira J Goldberg; Prabhakara R Nagareddy; Andrew J Murphy
Journal:  J Clin Invest       Date:  2017-05-15       Impact factor: 14.808

3.  Signaling profiling at the single-cell level identifies a distinct signaling signature in murine hematopoietic stem cells.

Authors:  Juan Du; Jinyong Wang; Guangyao Kong; Jing Jiang; Jingfang Zhang; Yangang Liu; Wei Tong; Jing Zhang
Journal:  Stem Cells       Date:  2012-07       Impact factor: 6.277

4.  Lnk deficiency partially mitigates hematopoietic stem cell aging.

Authors:  Alexey Bersenev; Krasimira Rozenova; Joanna Balcerek; Jing Jiang; Chao Wu; Wei Tong
Journal:  Aging Cell       Date:  2012-08-27       Impact factor: 9.304

5.  14-3-3 regulates the LNK/JAK2 pathway in mouse hematopoietic stem and progenitor cells.

Authors:  Jing Jiang; Joanna Balcerek; Krasimira Rozenova; Ying Cheng; Alexey Bersenev; Chao Wu; Yiwen Song; Wei Tong
Journal:  J Clin Invest       Date:  2012-05-01       Impact factor: 14.808

Review 6.  Thrombopoietin and hematopoietic stem cells.

Authors:  Carolyn A de Graaf; Donald Metcalf
Journal:  Cell Cycle       Date:  2011-05-15       Impact factor: 4.534

7.  NuRD mediates activating and repressive functions of GATA-1 and FOG-1 during blood development.

Authors:  Annarita Miccio; Yuhuan Wang; Wei Hong; Gregory D Gregory; Hongxin Wang; Xiang Yu; John K Choi; Suresh Shelat; Wei Tong; Mortimer Poncz; Gerd A Blobel
Journal:  EMBO J       Date:  2009-11-19       Impact factor: 11.598

8.  Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis.

Authors:  Brian J Lannutti; Angela Epp; Jacqueline Roy; Junmei Chen; Neil C Josephson
Journal:  Blood       Date:  2008-09-16       Impact factor: 22.113

9.  Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2.

Authors:  Alexey Bersenev; Chao Wu; Joanna Balcerek; Wei Tong
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

10.  Genome-wide lineage-specific transcriptional networks underscore Ikaros-dependent lymphoid priming in hematopoietic stem cells.

Authors:  Samuel Yao-Ming Ng; Toshimi Yoshida; Jiangwen Zhang; Katia Georgopoulos
Journal:  Immunity       Date:  2009-04-02       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.